SFOSF 2.79 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| Range: | 1.502-2.435 | Vol Avg: | 2157 | Last Div: | 0.04 | Changes: | -0.25 |
| Beta: | 0.71 | Cap: | 9.18B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Apr 21 2014 | Empoloyees: | 39309 | ||
| CUSIP: | CIK: | ISIN: | CNE100001M79 | Country: | CN | ||
| CEO: | Mr. Deyong Wen | Website: | https://www.fosunpharma.com | ||||
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow